Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with an anti-HIV drug containing
ritonavir and Agenerase is safe and can lower the level of HIV in the blood in patients who
have failed an anti-HIV drug treatment containing nelfinavir.